Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn about a recent article by Roberto Primi et al., published in Scientific Reports, adding:
“Interesting perspective.
This study shows that OHCA is not distributed evenly across a population – geography, age structure, population density and socioeconomic factors all influence where the burden is concentrated.
But there is another dimension we should consider: time and therapeutic availability.
If every minute matters, should we rethink how we equip EMS – particularly helicopters and other prehospital systems?
We need solutions that can bridge the patient to definitive hospital treatment: maintaining oxygen delivery during the critical transport window, when blood products or other advanced therapies may not be immediately available.
This is where a donor-independent oxygenation solution such as BHOC – Biological Hemoglobin Oxygen Carrier could play a complementary role – not replacing blood or hospital treatment, but supporting oxygen delivery and helping bridge the patient from the point of emergency to the hospital where definitive treatment can be delivered.
The future of emergency care may not only be about getting the patient to hospital faster.
It also about bringing therapeutic capability closer to the patient.
Because when every minute matters, time itself becomes a therapeutic resource.”
Title: Spatial inequalities in out-of-hospital cardiac arrest in Lombardy, Italy are associated with ageing, population density and low income
Authors: Roberto Primi, Stefania Bertazzon, Simona Villani, Sara Bendotti, Leila Ulmanova, Alessia Currao, Gianluca Marconi, Maurizio Migliari, Gabriele Mario Perotti, Enrico Baldi, Leonardo De Luca, Simone Savastano

Other posts featuring Archil Jaliashvili on Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience